Aromatic pyrrolidine amide prolyl endopeptidase inhibitors

Abstract

A series of aromatic pyrrolidine derivatives and suitable pharmaceutically acceptable salts thereof are disclosed. These compounds are useful as PEP inhibitors in the treatment of Alzheimer's disease, amnesia, dementia, anxiety ischemia, or stroke.

Dependencies are inferred from the claim text.